Cholangitis and Erythema multiforme

Summary:

Erythema multiforme is found among people with Cholangitis, especially for people who are female, 60+ old.

The study analyzes which people have Erythema multiforme with Cholangitis. It is created by eHealthMe based on reports of 32 people who have Cholangitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Cholangitis?

Cholangitis (infection of the bile duct) is found to be associated with 658 drugs and 749 conditions by eHealthMe. Check the latest studies of Cholangitis.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 1,705 drugs and 2,920 conditions by eHealthMe. Check the latest studies of Erythema multiforme.



On Jul, 15, 2026

32 people who have Cholangitis and Erythema Multiforme are studied.

Would you have Erythema multiforme when you have Cholangitis?

Gender of people who have Cholangitis and experienced Erythema Multiforme *:

  • female: 71.88 %
  • male: 28.12 %

Age of people who have Cholangitis and experienced Erythema Multiforme *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.25 %
  • 50-59: 3.12 %
  • 60+: 90.62 %

Common co-existing conditions for these people *:

  1. Itching: 15 people, 46.88%
  2. Hypotension (abnormally low blood pressure): 13 people, 40.62%
  3. Diarrhea: 13 people, 40.62%
  4. Pain: 12 people, 37.50%
  5. Hyperthyroidism (over activity of the thyroid gland): 11 people, 34.38%
  6. Oedema (fluid collection in tissue): 11 people, 34.38%
  7. Nausea (feeling of having an urge to vomit): 11 people, 34.38%
  8. Hypokalemia (low potassium): 11 people, 34.38%
  9. Diabetes: 10 people, 31.25%
  10. Gallstones (stone formation by bile component): 8 people, 25.00%

Common drugs taken by these people *:

  1. Aldactone: 12 people, 37.50%
  2. Dimenhydrinate: 8 people, 25.00%
  3. Heparin: 8 people, 25.00%
  4. Pentazocine: 7 people, 21.88%
  5. Metronidazole: 7 people, 21.88%
  6. Omeprazole: 6 people, 18.75%
  7. Potassium Chloride: 6 people, 18.75%
  8. Sodium Chloride: 6 people, 18.75%
  9. Mcp: 5 people, 15.62%
  10. Insulin: 4 people, 12.50%

Common symptoms for these people *:

  1. Rashes (redness): 15 people, 46.88%
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 14 people, 43.75%
  3. Circulatory Collapse: 13 people, 40.62%
  4. Skin Exfoliation (removal of the oldest dead skin cells): 12 people, 37.50%
  5. Lip Erosion (peeling off of lip): 11 people, 34.38%
  6. Cardiac Arrest: 11 people, 34.38%
  7. Conjunctivitis (pink eye): 11 people, 34.38%
  8. Itching: 11 people, 34.38%
  9. Acute Generalised Exanthematous Pustulosis (acute febrile drug eruption): 9 people, 28.12%
  10. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Erythema multiforme?

- Check whether Erythema multiforme is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Erythema multiforme:

All the conditions that are associated with Erythema multiforme:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Erythema multiforme and Cholangitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: